BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32401421)

  • 1. Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy.
    Liu M; Li C
    Chempluschem; 2020 May; 85(5):948-957. PubMed ID: 32401421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review.
    Kue CS; Ng SY; Voon SH; Kamkaew A; Chung LY; Kiew LV; Lee HB
    Photochem Photobiol Sci; 2018 Nov; 17(11):1691-1708. PubMed ID: 29845993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New BODIPYs for photodynamic therapy (PDT): Synthesis and activity on human cancer cell lines.
    Caruso E; Malacarne MC; Marras E; Papa E; Bertato L; Banfi S; Gariboldi MB
    Bioorg Med Chem; 2020 Nov; 28(21):115737. PubMed ID: 33065434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light-activatable cannabinoid prodrug for combined and target-specific photodynamic and cannabinoid therapy.
    Ling X; Zhang S; Liu Y; Bai M
    J Biomed Opt; 2018 Oct; 23(10):1-9. PubMed ID: 30334393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer.
    Nguyen VN; Yan Y; Zhao J; Yoon J
    Acc Chem Res; 2021 Jan; 54(1):207-220. PubMed ID: 33289536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Ethacrynic Acid-Brominated BODIPY Photosensitizer (EA-BPS) Construct Enhances the Lethality of Reactive Oxygen Species in Hypoxic Tumor-Targeted Photodynamic Therapy.
    Won M; Koo S; Li H; Sessler JL; Lee JY; Sharma A; Kim JS
    Angew Chem Int Ed Engl; 2021 Feb; 60(6):3196-3204. PubMed ID: 33155344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-IR absorbing BODIPY derivatives as glutathione-activated photosensitizers for selective photodynamic action.
    Turan IS; Cakmak FP; Yildirim DC; Cetin-Atalay R; Akkaya EU
    Chemistry; 2014 Dec; 20(49):16088-92. PubMed ID: 25345802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glutathione-activated phthalocyanine-based photosensitizer for photodynamic therapy.
    He H; Lo PC; Ng DK
    Chemistry; 2014 May; 20(21):6241-5. PubMed ID: 24737172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy.
    Chen C; Wang J; Li X; Liu X; Han X
    Comb Chem High Throughput Screen; 2017; 20(5):414-422. PubMed ID: 28088891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosome-targeted Aza-BODIPY photosensitizers for anti-cancer photodynamic therapy.
    Hu M; Dong X; Zhao W
    Bioorg Med Chem; 2024 Feb; 99():117583. PubMed ID: 38198943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles.
    Zhao B; Yin JJ; Bilski PJ; Chignell CF; Roberts JE; He YY
    Toxicol Appl Pharmacol; 2009 Dec; 241(2):163-72. PubMed ID: 19695274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design of Phosphorescent Iridium(III) Complexes for Selective Glutathione Sensing and Amplified Photodynamic Therapy.
    Huang T; Yu Q; Liu S; Zhang KY; Huang W; Zhao Q
    Chembiochem; 2019 Feb; 20(4):576-586. PubMed ID: 30267457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a red absorbing Se-rhodamine photosensitizer and its application for bio-orthogonally activatable photodynamic therapy.
    Lv W; Chi S; Feng W; Liang T; Song D; Liu Z
    Chem Commun (Camb); 2019 Jun; 55(49):7037-7040. PubMed ID: 31143887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and Development of Natural Products and their Derivatives as Photosensitizers for Photodynamic Therapy.
    Xiao Q; Wu J; Pang X; Jiang Y; Wang P; Leung AW; Gao L; Jiang S; Xu C
    Curr Med Chem; 2018; 25(7):839-860. PubMed ID: 28831916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells.
    Yuan B; Wang H; Xu JF; Zhang X
    ACS Appl Mater Interfaces; 2020 Jun; 12(24):26982-26990. PubMed ID: 32432853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axially substituted silicon(IV) phthalocyanine and its quaternized derivative as photosensitizers towards tumor cells and bacterial pathogens.
    Ömeroğlu İ; Kaya EN; Göksel M; Kussovski V; Mantareva V; Durmuş M
    Bioorg Med Chem; 2017 Oct; 25(20):5415-5422. PubMed ID: 28807573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatile Strategy To Generate a Rhodamine Triplet State as Mitochondria-Targeting Visible-Light Photosensitizers for Efficient Photodynamic Therapy.
    Liu C; Zhou L; Wei F; Li L; Zhao S; Gong P; Cai L; Wong KM
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8797-8806. PubMed ID: 30730131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phthalocyanine-based photosensitizers: more efficient photodynamic therapy?
    Ng DK
    Future Med Chem; 2014; 6(18):1991-3. PubMed ID: 25531964
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy.
    Jia X; Jia L
    Curr Drug Metab; 2012 Oct; 13(8):1119-22. PubMed ID: 22380016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-substituted phthalocyanine photosensitizers: design, synthesis, photophysicochemical and photobiological studies.
    Göksel M; Durmuş M; Atilla D
    Photochem Photobiol Sci; 2016 Oct; 15(10):1318-1329. PubMed ID: 27714248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.